CCL17 and prostate cancer: High expression of CCL17 has been linked to worse prognosis in prostate cancer, renal cancer, and testicular cancer (18, 37, 38), and increased expression has also been observed in chronic viral infections such as hepatitis C and human papillomavirus, which are associated with malignant transformation (39, 40).